Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
14381
Data_Sheet_1_v1_Significance of Pseudomeningocele After Decompressive Surgery for Chiari I Malformation.pdf
Published 2022“…</p>Results<p>PMCs were recognized in 27 (35.5%) patients, of whom 3 (11.1%) required reoperation. …”
-
14382
Data_Sheet_1_v1_Significance of Pseudomeningocele After Decompressive Surgery for Chiari I Malformation.pdf
Published 2022“…</p>Results<p>PMCs were recognized in 27 (35.5%) patients, of whom 3 (11.1%) required reoperation. …”
-
14383
Data_Sheet_2_v1_Significance of Pseudomeningocele After Decompressive Surgery for Chiari I Malformation.pdf
Published 2022“…</p>Results<p>PMCs were recognized in 27 (35.5%) patients, of whom 3 (11.1%) required reoperation. …”
-
14384
Electrospinning Nonspinnable Sols to Ceramic Fibers and Springs
Published 2024“…However, the addition of polymers to the spinning solution makes the process more complex, increases the processing time, and results in porous mechanically weak ceramic fibers. Herein, we develop a coelectrospinning technique, where a nonspinnable sol (<10 mPa s) consisting of only the ceramic precursor(s) and solvent(s) is encapsulated inside a polymeric shell, forming core–shell precursor fibers that are further calcined into ceramic fibers with reduced porosity, decreased surface defects, uniform crystal packing, and controlled diameters. …”
-
14385
Electrospinning Nonspinnable Sols to Ceramic Fibers and Springs
Published 2024“…However, the addition of polymers to the spinning solution makes the process more complex, increases the processing time, and results in porous mechanically weak ceramic fibers. Herein, we develop a coelectrospinning technique, where a nonspinnable sol (<10 mPa s) consisting of only the ceramic precursor(s) and solvent(s) is encapsulated inside a polymeric shell, forming core–shell precursor fibers that are further calcined into ceramic fibers with reduced porosity, decreased surface defects, uniform crystal packing, and controlled diameters. …”
-
14386
Electrospinning Nonspinnable Sols to Ceramic Fibers and Springs
Published 2024“…However, the addition of polymers to the spinning solution makes the process more complex, increases the processing time, and results in porous mechanically weak ceramic fibers. Herein, we develop a coelectrospinning technique, where a nonspinnable sol (<10 mPa s) consisting of only the ceramic precursor(s) and solvent(s) is encapsulated inside a polymeric shell, forming core–shell precursor fibers that are further calcined into ceramic fibers with reduced porosity, decreased surface defects, uniform crystal packing, and controlled diameters. …”
-
14387
Electrospinning Nonspinnable Sols to Ceramic Fibers and Springs
Published 2024“…However, the addition of polymers to the spinning solution makes the process more complex, increases the processing time, and results in porous mechanically weak ceramic fibers. Herein, we develop a coelectrospinning technique, where a nonspinnable sol (<10 mPa s) consisting of only the ceramic precursor(s) and solvent(s) is encapsulated inside a polymeric shell, forming core–shell precursor fibers that are further calcined into ceramic fibers with reduced porosity, decreased surface defects, uniform crystal packing, and controlled diameters. …”
-
14388
-
14389
MOLECULAR FEATURES OF TRIPLE NEGATIVE BREAST CANCER STEM CELLS: A GENE EXPRESSION PROFILING ANALYSIS OF MDA-MB-231 CELLS
Published 2021“…Triple negative breast cancer (TNBC) is a chemoresistant subtype of female breast tumors. …”
Get full text
-
14390
Data Sheet 7_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
14391
Data Sheet 6_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
14392
Data Sheet 1_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
14393
Data Sheet 3_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
14394
Data Sheet 8_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
14395
Data Sheet 4_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
14396
Data Sheet 2_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
14397
-
14398
-
14399
-
14400